J. Collette

University of Melbourne — Australia

Medicine · Health Sciences

24h-index2.2kcitations93works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone health and osteoporosis research(25), Bone health and treatments(17), Bone Metabolism and Diseases(15), Vitamin D Research Studies(7), Estrogen and related hormone effects(6)

Publications92 total

Membrane tension can enhance adaptation to maintain polarity of migrating cells
2020· 2 citedOpen Access
Republished: Value of biomarkers in osteoarthritis: current status and perspectives
Postgraduate Medical Journal·2014· 73 citedOpen Access
Correction of vitamin D insufficiency with combined strontium ranelate and vitamin D3 in osteoporotic patients
European Journal of Endocrinology·2013· 8 citedOpen Access
Value of biomarkers in osteoarthritis: current status and perspectives
Annals of the Rheumatic Diseases·2013· 322 citedOpen Access
PLATELET-RICH PLASMA (PRP) TO TREAT CHRONIC UPPER PATELLAR TENDINOPATHIES
British Journal of Sports Medicine·2013· 5 cited
Serum sclerostin levels in men with idiopathic osteoporosis
European Journal of Endocrinology·2013· 32 citedOpen Access
Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids
Lara D. Veeken·2013· 18 citedOpen Access
Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women
Bone·2012· 11 cited
Journal of Aviation Technology and Engineering
Journal of Aviation Technology and Engineering·2011· 11 citedOpen Access
The effects of strontium ranelate on biochemical markers of bone turnover and their relationship with bone mineral density: reply to Stepan et al.
Osteoporosis International·2010· 5 cited
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years
Osteoporosis International·2009· 33 cited
[Interest of monoclonal antibodies in biomedical laboratory analysis].
PubMed·2009· 1 cited
Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover
Osteoporosis International·2009· 23 citedOpen Access
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
Osteoporosis International·2009· 197 citedOpen Access
Assessment of determinants for osteoporosis in elderly men
Osteoporosis International·2008· 19 cited
A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder
Schizophrenia Research·2008· 39 citedOpen Access
Adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder: relationships with metabolic syndrome and glucose abnormalities
Diabetologia·2008
Le ranélate de strontium diminue le risque de fractures vertébrales quel que soit le niveau initial de remodelage osseux
Revue du Rhumatisme·2007
La dissociation entre formation et résorption osseuses est mise en évidence par des modifications des marqueurs biochimiques chez des patientes traitées par ranélate de strontium
Revue du Rhumatisme·2007
STRONTIUM RANELATE DECREASES VERTEBRAL FRACTURE RISK WHATEVER THE LEVEL OF PRETREATMENT BONE TURNOVER MARKERS
Osteoporosis and Bone Diseases·2007Open Access
page 1 of 5Next →

Frequent Co-authors

Jean‐Yves Reginster(16), P Franchimont(13), Olivier Bruyère(11), Adelin Albert(8), Rita Deroisy(7), J.-Y. Reginster(4), P.F. Zangerle(4), Brigitte Zegels(4), Yves Henrotin(4), D. Denis(4), Claus Christiansen(3), Maria Luisa Brandi(3), René Rizzoli(3), Nathalie Franchimont(3), Vincent Bonhomme(3), Gustave Moonen(3), MP Lecart(3), P Franchimont(3), JY Reginster(3), Martin Lotz(2)